EP2580155A1 - Three-dimensional metal-coated nanostructures on substrate surfaces, method for producing same and use thereof - Google Patents
Three-dimensional metal-coated nanostructures on substrate surfaces, method for producing same and use thereofInfo
- Publication number
- EP2580155A1 EP2580155A1 EP11724961.5A EP11724961A EP2580155A1 EP 2580155 A1 EP2580155 A1 EP 2580155A1 EP 11724961 A EP11724961 A EP 11724961A EP 2580155 A1 EP2580155 A1 EP 2580155A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- nanoparticles
- metal
- substrate surface
- structures
- etching
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B81—MICROSTRUCTURAL TECHNOLOGY
- B81C—PROCESSES OR APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OR TREATMENT OF MICROSTRUCTURAL DEVICES OR SYSTEMS
- B81C1/00—Manufacture or treatment of devices or systems in or on a substrate
- B81C1/00015—Manufacture or treatment of devices or systems in or on a substrate for manufacturing microsystems
- B81C1/00023—Manufacture or treatment of devices or systems in or on a substrate for manufacturing microsystems without movable or flexible elements
- B81C1/00031—Regular or irregular arrays of nanoscale structures, e.g. etch mask layer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/553—Metal or metal coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6848—Needles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B81—MICROSTRUCTURAL TECHNOLOGY
- B81B—MICROSTRUCTURAL DEVICES OR SYSTEMS, e.g. MICROMECHANICAL DEVICES
- B81B2203/00—Basic microelectromechanical structures
- B81B2203/03—Static structures
- B81B2203/0361—Tips, pillars
Definitions
- Three-dimensionally nanostructured substrate surfaces which can be functionalized with binding molecules to allow selective attachment of biological structures and molecules, particularly cells, are well known in the art.
- Nagrath et al. describe in Nature, 450, 1235-1239 (2007), the preparation of surfaces with column structures of micron-length length for the accumulation of circulating tumor cells and Wang et al. describe in Angew. Chem. Int. Ed., 48, 8970-8973 (2009), the production of Si nanopillars on a Si wafer by wet-chemical etching and the functionalization with a specific antibody, anti-EpCAM, which allows the selective attachment of certain tumor cells.
- the preparation of these nanostructures is relatively time-consuming and costly and their functionalization also.
- the published structures move in the ⁇ - length range (100-200 nm diameter, length 10 m).
- these structures are not ideal sizes for the immobilization of ordered molecular surfaces.
- the number of molecules per unit area in these structures in the ⁇ range is reduced in comparison to nanostructures.
- the controlled long-term cultivation and differentiation of cells is not feasible with the published structure functionalization.
- a simple and inexpensive method of etching three-dimensional nanostructures for optical elements can be generated directly on quartz glass, is in interpreting ⁇ rule published patent application DE 10 2007 014 538, AI and in the corresponding International Publication No. WO 2008/116616 Al and in Lohmüller et al., NANO LETTERS 2008, vol. 8, no. 5 1429-1433.
- the nanopillars disclosed therein are not metal-covered and functionalization with biological binding molecules is not suggested.
- These nano-pillars of the prior art have after the etching process no metal particles or metal deposits on their upper ⁇ surface, since the metal previously used as a mask is completely vaporized in the etching process. This is imperative for the functionality of the structures described there as an optical element.
- an object of the present invention was to provide, in particular for bio ⁇ medical, bioanalytical and biosensory applications, improved three - dimensional nanostructures on a substrate surface, which can be functionalized easily with a variety of binding molecules and the selective attachment of biological Structures and molecules, as well as cells or cell aggregates, with high efficiency and Aus ⁇ booty enable.
- the method according to the invention for producing columnar or conical nanostructures having on their upper side a metal covering on a substrate surface according to claim 1 comprises at least the following steps:
- step d) etching the substrate surface covered with the nanoparticles obtained in step c) at a depth of 10-500 nm, wherein the nanoparticles act as an etching mask and the etching parameters are adjusted so that pillar structures or conical structures are formed underneath the nanoparticles and the nanoparticles are obtained as structural coverage stay.
- the primary substrate surface is basically not particularly limited and may include any material that can be coated with Si or Si0 2 .
- the substrate may be selected, for example, from glass, silicon, Si0 2 , semiconductors, metals, polymers, etc. Particularly for optical applications, transparent substrates are preferred, but not relevant in biomedical applications.
- the primary substrate surface may be provided with a, preferably 50-500 nm, thick silicon layer by chemical vapor deposition or plasma deposition or other method known in the art. Subsequently, the oxidation is carried out, for example by means of oxygen plasma or another suitable oxidizing agent, to produce a Si0 2 layer on the primary substrate surface.
- the substrate surface it is preferred, but not essential, for the substrate surface to be covered in step b) with nanoparticles by means of a micelle-diblock copolymer nanolithography technique, as described, for example, in EP 1 027 157 Bl and DE 197 47 815 A1.
- a micellar solution of a block copolymer is deposited onto a substrate, for example by dip coating, and forms, under suitable conditions on the surface, an ordered film structure of chemically distinct polymer domains, including, but not limited to, type, molecular weight, and concentration of the block copolymer.
- the micelles in the solution can be loaded with inorganic salts, which can be oxidized or reduced to inorganic nanoparticles after deposition with the polymer film.
- a further development of this technique described in the patent application DE 10 2007 017 032 AI, makes it possible to set both the lateral separation length of the polymer domains mentioned and thus also of the resulting nanoparticles as well as the size of these nanoparticles by various measures so precisely flat that nanostructured surfaces with desired distance and / or size gradient can be produced.
- nanoparticle arrangements made with such a micellar nanolithography technique have a quasi-hexagonal pattern.
- the material of the nanoparticles is not particularly limited and may include any material known in the art for such nanoparticles.
- this is a metal or metal oxide.
- a metal or metal oxide A wide range of suitable materials is mentioned in DE 10 2007 014 538 A1.
- Specific examples of a preferable metal oxide are titanium oxide, iron oxide and cobalt oxide.
- Preferred examples of a metal are chromium, titanium, noble metals, eg gold, palladium and platinum, and particularly preferred is gold.
- particle as used herein also includes a “cluster”, in particular as described and defined in DE 10 2007 014 538 AI and DE 197 47 815 AI, and both terms can be used interchangeably herein.
- the enlargement of the metal nanoparticles by electroless deposition of elemental metal on the nanoparticles in step c) involves a reduction of the corresponding metal salt.
- a chemical agent e.g. Hydrazine or other suitable chemical reducing agent, or high-energy radiation such as electron radiation or light (as described in DE 10 2009 053 406.7) can be used.
- the method according to the invention in the etching step d) can comprise one or more treatments with the same etchant and / or with different etchants.
- the etchant may in principle be any etchant known in the art and suitable for the respective substrate surface.
- the etchant from the group of chlorine gases, eg Cl 2 , BC1 3 and other gaseous chlorine compounds, fluorohydrocarbons, eg CHF 3 , CH 2 F 2 , CH 3 F, fluorocarbons, eg CF 4 , C 2 F 8 , oxygen, argon, SF 6 and mixtures thereof.
- CHF 3 is used in combination with SF 4 in at least one treatment step as an etchant.
- the duration of the entire etching treatment is typically in the range from 10 s to 60 minutes, preferably 1 to 15 Minu ⁇ th.
- step d) a plasma etching process (reactive ion etching") as described in DE 10 2007 014 538 AI and Loh ⁇ müller et al., (NANO LETTERS 2008, Vol. 8, No. 5, 1429-1433, described and Preferably, a mixture of CHF 3 with CF 4 is used.
- reactive ion etching reactive ion etching
- the resulting nanostructures typically have a diameter in the range of 10-100 nm, preferably 10-30 nm, and a height of 10-500 nm, preferably 10-150 nm.
- the average distances of the nanostructures are preferably in a range of 15 to 200 nm.
- the nanoparticles used as the etching mask have a predetermined two-dimensional geometric arrangement on the substrate surface. Such an arrangement has as a characteristic to predetermined minimum or average particle distances, said predetermined particle spacing may be the same in all areas of the substrate surface or may have different areas un ⁇ ter Kunststoffliche predetermined particle distances.
- Such a geometric arrangement can in principle be re ⁇ al instrument with any suitable method of the prior art, in particular micellar nanolithography as described above.
- the nanostructures obtained after the etching step are preferably functionalized with at least one binding molecule which enables or facilitates the attachment of biological structures, molecules, microorganisms or cells.
- the binding molecule is a molecule specifically binding to surface structures of cells or constituents of the extracellular matrix or a molecule which can later be taken up by the cells cultured on the substrate.
- the binding molecule is selected from the group consisting of proteins or low molecular weight peptides, in particular antibodies and fragments thereof, as well as enzymatically active proteins or domains thereof, lectins, carbohydrates, proteoglycans, glycoproteins, nucleic acids such as ssDNA, dsDNA, RNA, siRNA, lipids or glycolipids selected.
- the nanostructures are provided with at least one binding molecule selected from molecular which binds to cell adhesion receptors (CAM) of cells, specific receptors or binding sites to viruses, proteins or nucleic acids, chemically functionalized.
- CAM cell adhesion receptors
- the binding molecule is selected from fibronectin, laminin, fibrinogen, tenascin, VCAM-1, MadCAM-1, collagen or a cell adhesion receptor, particularly integrins, specific binding fragment thereof or a cell adhesion receptor specific binding derivative thereof.
- Signaling molecules such as the entire receptor families of EGFR, FGFR and Notch / Jagged-1, can also be addressed with these molecules.
- the functionalization occurs by immobilization of the binding molecule on the metal cover of the nanostructures.
- Methods for immobilizing binding molecules on metal substrates, in particular gold nanoparticles are known in principle and are described, for example, in Arnold et al., ChemPhysChem (2004) 5, 383-388, Wolfram et al., Bioin terphases 2007, Mar; 2 (1): 4-8, Ibii et al., Anal Chem., 2010 May 15, 82 (10): 4229-35, Sakata et al., Langmuir. 2007, Feb. 27; 23 (5): 2269-72 and Mateo-Marti et al., Langmuir. 2005, Oct 11; 21 (21): 9510-7.
- the three-dimensional nanostructures used according to the invention can typically be biofunctionalized at room temperature within half an hour and are therefore clearly superior in terms of time and expense to the three-dimensional microstructures of the prior art described in the introduction of the present text.
- the orientation-specific immobilization of recombinant proteins is mög ⁇ Lich for example with Ni-NTA complex reactions (Wolfram et al., Supra). Furthermore, all proteins and antibodies can be covalently attached to gold and silver nanoparticles using DTSSP and related thiol-based linkers (see Example 2). Immobilization of antibodies or fragments thereof is also possible via immobilization of protein A / G or L.
- the bioactive molecules can be bound directly or indirectly via linker systems. Chemisorption, affinity-based and protein-mediated immobilizations can be used.
- the functionalized nanostructured substrate surfaces are particularly suitable for the identification of biological ⁇ rule target structures, molecules, or cells Microorganisms in a sample and / or the insulation thereof.
- the sample may for example be a body fluid, especially blood, interstitial fluids or mucous or fes ⁇ te tissue sample.
- the targets may be molecules which are known as diagnostic marker or target cells, for example, certain tumor cells, trophoblasts or alterations ⁇ re desired cell types or components thereof.
- An essential aspect of the invention relates to a Vorrich ⁇ processing for the specific attachment of biological Zielstruktu ⁇ reindeer, molecules, or cells
- Microorganisms which defines in a sample, particularly a sample as above, are present that environmentally such a nanostructured substrate surface summarizes ,
- this device is part of a probe which is designed so that it can be introduced into a living organism and brought into contact with its body fluids.
- the device is characterized in that at least a part of the probe has the shape of a needle and in the bloodstream of a living organism can be introduced.
- targeted specific circulating cell types can be isolated from the blood and identified.
- the needle dimensions are preferably in those known for medical applications of needles and cannulas (eg for injections and blood withdrawals) areas and can be easily optimized by routine experimentation.
- Fig. 1 shows schematically the main steps of the method according to the invention
- a primary substrate surface was provided with a 50-500 nm thick silicon layer by chemical vapor deposition or plasma deposition. Then, it was activated in oxygen plasma (150 W, 0.1 mbar, 30 minutes) to produce a Si0 2 layer on the primary substrate surface (Fig. 1b).
- the Sio 2 substrate surface formed in the first step was covered by micellar nanolithography with gold nanoparticles in a defined arrangement (FIG. 1 c).
- a micellar solution of a block copolymer eg polystyrene (n) -b-poly (2-vinylpyridine (m)
- a surface is formed on the surface.
- ordered film structure is formed by polymer domains.
- the micelles in the solution are loaded with a gold salt, preferably HAuCl 4 , which is reduced to the gold nanoparticles after deposition with the polymer film.
- a short hydrogen plasma activation 200 W, 0.5 mbar, 1 minute is performed to generate gold particle nuclei in the micelle cores ( Figure 1d).
- the electroless deposition was carried out by immersing the Ober ⁇ surface in a solution of 0.1% HAuCl 4 and 0.2 mM NH 3 0HC1 (1: 1) for 3.5 minutes. Under these reducing conditions, the gold salt in the solution is reduced to elemental gold, which selectively deposits on and enlarges the gold particle nuclei (Fig. Le). Now the polymer micelles can be removed from the surface and this is achieved by exposing the surface to a hydrogen plasma (150 W, 0.4 mbar, 45 minutes.) At this time, the substrate surface is covered with a quasi-hexagonal two-dimensional array of gold. Decorated nanoparticles of desired size (FIG)
- the etching of the covered with gold nanoparticles Si0 2 layer was carried out at a desired depth.
- a "Reactive Ion Etcher” from Oxford Plasma, instrument: PlasmaLab 80 plus was used, but other devices known in the art are basically also suitable.
- the etching was carried out with a mixture of the process gases CHF3 and CF4 (10: 1) at a total pressure of 10 mTorr, a temperature of 20 ° C and an energy of 30 W.
- the duration of the etching treatment varied in a range of about 1-15 minutes depending on the desired etching depth.
- columnar or frustoconical nanostructures were obtained, which still had gold nanoparticles on top ( Figure lg).
- Protocol C A further protocol is the direct Immobi ⁇ capitalization of proteins by chemisorption.
- protein A, G or L Tris-HCl pH 8 9.5
- the functionalized substrate surfaces (FIG. 1 h) can now be used for binding target structures, in particular target cells (FIG. 1 i).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Manufacturing & Machinery (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Inorganic Chemistry (AREA)
- Microbiology (AREA)
- Optics & Photonics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102010023490A DE102010023490A1 (en) | 2010-06-11 | 2010-06-11 | Three-dimensional metal-covered nanostructures on substrate surfaces, methods for their production and their use |
PCT/EP2011/002670 WO2011154105A1 (en) | 2010-06-11 | 2011-05-30 | Three-dimensional metal-coated nanostructures on substrate surfaces, method for producing same and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2580155A1 true EP2580155A1 (en) | 2013-04-17 |
Family
ID=44626978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11724961.5A Withdrawn EP2580155A1 (en) | 2010-06-11 | 2011-05-30 | Three-dimensional metal-coated nanostructures on substrate surfaces, method for producing same and use thereof |
Country Status (4)
Country | Link |
---|---|
US (1) | US20130236881A1 (en) |
EP (1) | EP2580155A1 (en) |
DE (1) | DE102010023490A1 (en) |
WO (1) | WO2011154105A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013007354A1 (en) | 2011-07-08 | 2013-01-17 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | A method for preventing or reducing the production of biofilms formed by microorganisms using nanostructured surfaces |
WO2013049636A1 (en) * | 2011-09-30 | 2013-04-04 | The Regents Of The University Of Michigan | System for detecting rare cells |
WO2014070776A1 (en) | 2012-10-29 | 2014-05-08 | The Regents Of The University Of Michigan | Microfluidic device and method for detecting rare cells |
US9913603B2 (en) * | 2014-02-12 | 2018-03-13 | California Institute Of Technology | Reflowed gold nanostructures for surface enhanced raman spectroscopy |
WO2015123457A1 (en) * | 2014-02-12 | 2015-08-20 | California Institute Of Technology | Plasmonics nanostructures for multiplexing implantable sensors |
CN103919561B (en) * | 2014-03-25 | 2015-08-19 | 天津大学 | Based on the flattening type optical fiber ATR glucose sensor that metal nanoparticle strengthens |
US9475692B2 (en) * | 2014-07-22 | 2016-10-25 | Qorvo Us, Inc. | Radio frequency (RF) microelectromechanical systems (MEMS) devices with gold-doped silicon |
US9846125B2 (en) | 2014-09-05 | 2017-12-19 | California Institute Of Technology | Surface enhanced Raman spectroscopy detection of gases, particles and liquids through nanopillar structures |
WO2016036410A1 (en) | 2014-09-05 | 2016-03-10 | California Institute Of Technology | Multiplexed surface enhanced raman sensors for early disease detection and in-situ bacterial monitoring |
US9512000B2 (en) | 2014-12-09 | 2016-12-06 | California Institute Of Technology | Fabrication and self-aligned local functionalization of nanocups and various plasmonic nanostructures on flexible substrates for implantable and sensing applications |
US10317406B2 (en) | 2015-04-06 | 2019-06-11 | The Regents Of The University Of Michigan | System for detecting rare cells |
US9719926B2 (en) | 2015-11-16 | 2017-08-01 | International Business Machines Corporation | Nanopillar microfluidic devices and methods of use thereof |
US10361697B2 (en) * | 2016-12-23 | 2019-07-23 | Skyworks Solutions, Inc. | Switch linearization by compensation of a field-effect transistor |
US10422746B2 (en) | 2017-12-13 | 2019-09-24 | International Business Machines Corporation | Nanoscale surface with nanoscale features formed using diffusion at a liner-semiconductor interface |
CN116854024B (en) * | 2023-06-07 | 2024-03-15 | 武汉大学 | Preparation method of single or multiple nanoscale pore channels based on silicon wafer |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59809228D1 (en) | 1997-10-29 | 2003-09-11 | Univ Ulm | NANO STRUCTURES |
DE19747815A1 (en) | 1997-10-29 | 1999-05-06 | Univ Ulm | Production of surface-structured substrates used in the manufacture of electronic components |
US20090136785A1 (en) * | 2007-01-03 | 2009-05-28 | Nanosys, Inc. | Methods for nanopatterning and production of magnetic nanostructures |
DE102007014538A1 (en) | 2007-03-27 | 2008-10-02 | Carl Zeiss Ag | Method for producing an anti-reflection surface on an optical element and optical elements with an anti-reflection surface |
DE102007017032B4 (en) | 2007-04-11 | 2011-09-22 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for the production of surface size or distance variations in patterns of nanostructures on surfaces |
CN101827783A (en) * | 2007-06-21 | 2010-09-08 | 3M创新有限公司 | Methods of making hierarchical articles |
DE102008039798A1 (en) * | 2008-08-15 | 2010-02-25 | NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen | Method of transferring nanostructures into a substrate |
DE102009053406A1 (en) | 2009-11-16 | 2011-05-19 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for the spatially resolved enlargement of nanoparticles on a substrate surface |
-
2010
- 2010-06-11 DE DE102010023490A patent/DE102010023490A1/en not_active Withdrawn
-
2011
- 2011-05-30 EP EP11724961.5A patent/EP2580155A1/en not_active Withdrawn
- 2011-05-30 WO PCT/EP2011/002670 patent/WO2011154105A1/en active Application Filing
- 2011-05-30 US US13/703,054 patent/US20130236881A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO2011154105A1 * |
Also Published As
Publication number | Publication date |
---|---|
DE102010023490A1 (en) | 2011-12-15 |
WO2011154105A1 (en) | 2011-12-15 |
US20130236881A1 (en) | 2013-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2580155A1 (en) | Three-dimensional metal-coated nanostructures on substrate surfaces, method for producing same and use thereof | |
Zhou et al. | In vivo monitoring of oxygen in rat brain by carbon fiber microelectrode modified with antifouling nanoporous membrane | |
Kang et al. | Inkjet-printed biofunctional thermo-plasmonic interfaces for patterned neuromodulation | |
Santoro et al. | Interfacing electrogenic cells with 3D nanoelectrodes: position, shape, and size matter | |
Severyukhina et al. | Nanoplasmonic chitosan nanofibers as effective SERS substrate for detection of small molecules | |
DE69030811T2 (en) | RECEPTOR MEMBRANES AND SELECTIVE CONTROL OF THE ION FLOW BY IONOPHORES | |
DE10164309A1 (en) | Improved structured-functional binding matrices for biomolecules | |
EP1850890B1 (en) | Method for modifying a substrate | |
Szewczyk et al. | Polydopamine films: Electrochemical growth and sensing applications | |
EP2550353B1 (en) | Thermoreactive substrate with microgels, method for its preparation, and culture method for biological cells | |
DE102015004114B4 (en) | Surface enhancing plasmonic substrate | |
EP1899724A2 (en) | Electrode assembly, use thereof, and method for the production thereof | |
Yin et al. | Advanced metallic and polymeric coatings for neural interfacing: Structures, properties and tissue responses | |
EP2024069A1 (en) | Production of micro- and nanopore mass arrangements by self-organization of nanoparticles and sublimation technology | |
DE102004062573A1 (en) | Three-dimensional nano- and microstructured supports | |
EP2390310B9 (en) | Thermoresponsive multilayer substrate for biological cells | |
WO2008131714A2 (en) | Method and arrangement for electrically contacting an object surrounded by a membrane, using an electrode | |
Chandran et al. | New disposable nitric oxide sensor fabrication using GaN nanowires | |
WO2010075933A1 (en) | Substrate for selecting and specifically influencing the function of cells | |
Mao et al. | Biomimetic nanowire structured hydrogels as highly active and recyclable catalyst carriers | |
Morin et al. | Facile use of cationic hydrogel particles for surface modification of planar substrates toward multifunctional neural permissive surfaces: an in vitro investigation | |
Gudur et al. | Bio-applications of nanopillars | |
Gunning et al. | Dense arrays of micro-needles for recording and electrical stimulation of neural activity in acute brain slices | |
Ruhunage et al. | Hydrophilic micro-and macroelectrodes with antibiofouling properties for biomedical applications | |
WO2007003399A2 (en) | Electrode assembly, use thereof, and method for the production thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20121126 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: PURWANINGSIH, LINDARTI Inventor name: SPATZ, JOACHIM, P. Inventor name: SCHOEN, TOBIAS Inventor name: WOLFRAM, TOBIAS Inventor name: PACHOLSKI, CLAUDIA |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/553 20060101ALI20131030BHEP Ipc: A61B 5/145 20060101AFI20131030BHEP Ipc: B81C 1/00 20060101ALI20131030BHEP Ipc: A61B 5/00 20060101ALI20131030BHEP |
|
INTG | Intention to grant announced |
Effective date: 20131115 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20140326 |